Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml
Klin Monbl Augenheilkd
DOI: 10.1055/a-2243-4507
DOI: 10.1055/a-2243-4507
Der interessante Fall
Subkonjuktivale Dexamethason-Implantation
Subconjuctival Dexamethasone Implantation
Anamnese
Eine 58-jährige Patientin wurde uns aufgrund eines rezidivierenden Makulaödems links bei chronisch-rezidivierender Uveitis anterior (HLA-B27+) zur Durchführung einer erstmaligen Injektion von Ozurdex (700 µg Dexamethason-Implantat, Allergan, Irland) überwiesen. Die Patientin hatte zuvor beim niedergelassen Augenarzt subkonjunktivale Dexamethason-Injektionen bekommen, die jedoch keine Besserung des Makulaödems brachten. Eine systemische Therapie wurde von der Patientin grundsätzlich abgelehnt.
Publication History
Received: 30 September 2023
Accepted: 28 December 2023
Article published online:
26 March 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Gaballa SA, Kompella UB, Elgarhy O. et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res 2021; 11: 866-893
- 2 Kapoor KG, Wagner MG, Wagner AL. The Sustained-Release Dexamethasone Implant: Expanding Indications in Vitreoretinal Disease. Semin Ophthalmol 2015; 30: 475-481
- 3 Khurana RN, Appa SN, McCannel CA. et al. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies. Ophthalmology 2014; 121: 67-71
- 4 Betsch DM, Gupta RR. Management and Complications of Dexamethasone Intravitreal Implant Migration Into the Anterior Chamber. J Vitreoretin Dis 2022; 6: 432-436
- 5 Madi HA, Morgan SJ, Ghosh S. Corneal graft failure due to migration of Ozurdex implant into the anterior chamber. Am J Ophthalmol Case Rep 2017; 8: 25-27
- 6 Chen WL, Lin CT, Yao CC. et al. In-vitro effects of dexamethasone on cellular proliferation, apoptosis, and Na+-K+-ATPase activity of bovine corneal endothelial cells. Ocul Immunol Inflamm 2006; 14: 215-223
- 7 Fenolland JR, Sigaux M, Giraud JM. Inadvertent Subconjunctival Injection of a Dexamethasone Implant. JAMA Ophthalmol 2017; 135: e170106
- 8 Ong J, Davidoss NH, Bhosale A. et al. Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex). BMJ Case Rep 2020; 13: e235102
- 9 Mateo C, Alkabes M, Burés-Jelstrup A. Scleral fixation of dexamethasone intravitreal implant (OZURDEX) in a case of angle-supported lens implantation. Int Ophthalmol 2014; 34: 661-665
- 10 Herold TR, Liegl R, Koenig S. et al. Scleral Fixation of the Fluocinolone Acetonide Implant in Eyes with Severe Iris-Lens Diaphragm Disruption and Recalcitrant CME: The Fluocinolone-Loop-Anchoring Technique (FLAT). Ophthalmol Ther 2020; 9: 175-179
- 11 Tayyab H, Ahmed CN, Sadiq MAA. Efficacy and safety of Suprachoroidal Triamcinolone Acetonide in cases of resistant diabetic Macular Edema. Pak J Med Sci 2020; 36: 42-47
- 12 Olsen TW, Feng X, Wabner K. et al. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am J Ophthalmol 2006; 142: 777-787
- 13 Goldstein DA, Do D, Noronha G. et al. Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis. Transl Vis Sci Technol 2016; 5: 14